Bridging the gap between hospital and primary care: the pharmacist home visit

International Journal of Clinical Pharmacy
Hendrik T EnsingMarcel L Bouvy

Abstract

Bridging the gap between hospital and primary care is important as transition from one healthcare setting to another increases the risk on drug-related problems and consequent readmissions. To reduce those risks, pharmacist interventions during and after hospitalization have been frequently studied, albeit with variable effects. Therefore, in this manuscript we propose a three phase approach to structurally address post-discharge drug-related problems. First, hospitals need to transfer up-todate medication information to community pharmacists. Second, the key phase of this approach consists of adequate follow-up at the patients' home. Pharmacists need to apply their clinical and communication skills to identify and analyze drug-related problems. Finally, to prevent and solve identified drug related problems a close collaboration within the primary care setting between pharmacists and general practitioners is of utmost importance. It is expected that such an approach results in improved quality of care and improved patient safety.

References

Jan 25, 2005·BMJ : British Medical Journal·Richard HollandChristopher Hand
Sep 15, 2005·Archives of Internal Medicine·Eric A ColemanSung-joon Min
Sep 11, 2007·Journal of Evaluation in Clinical Practice·Claire ScullinJames C McElnay
Feb 5, 2008·Quality & Safety in Health Care·E M A WitheringtonA J Avery
Jan 6, 2009·Journal of the American Academy of Nurse Practitioners·Janice H RobinsonKaren A Dearing
May 26, 2010·Age and Ageing·Marta Garcia-CaballosAurora Bueno-Cavanillas
Jun 18, 2010·Patient Education and Counseling·Sander D BorgsteedePatricia M L A van den Bemt
Mar 12, 2011·International Journal of Cardiology·Anna BarkerWen Kwang Lim
Jun 27, 2012·Archives of Internal Medicine·Stephanie K MuellerJeffrey L Schnipper
Oct 4, 2012·Journal of Health Communication·Courtney CawthonSunil Kripalani
Nov 30, 2013·Journal of the American Medical Directors Association·Carolien G M SinoMarieke J Schuurmans
Apr 1, 2013·Therapeutic Advances in Drug Safety·Carolien M J van der LindenErik H M Korsten
Sep 15, 2014·BMC Health Services Research·Gijs HesselinkHub Wollersheim
Sep 23, 2014·BMC Health Services Research·Karen B FarrisJohn M Brooks

❮ Previous
Next ❯

Citations

Sep 25, 2016·Research in Social & Administrative Pharmacy : RSAP·Hendrik T EnsingMarcel L Bouvy
Sep 23, 2016·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Bruno MichelMorgane Beck
Mar 1, 2018·European Journal of Hospital Pharmacy. Science and Practice·Tina Hoff DuedahlTrine Graabæk
May 4, 2018·International Journal of Clinical Pharmacy·Hendrik T EnsingEllen S Koster
Jun 14, 2020·Research in Social & Administrative Pharmacy : RSAP·Sara DaliriFatma Karapinar-Çarkit
May 30, 2021·Research in Social & Administrative Pharmacy : RSAP·Elien B UitvlugtFatma Karapinar-Çarkit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.